Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Fabry Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Enzyme Replacement Therapy (ERT)
1.4.3 Chaperone Treatment
1.4.4 Substrate Reduction Therapy (SRT)
1.4.5 Others
1.5 Market by Application
1.5.1 Global Fabry Disease Treatment Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Fabry Disease Treatment Market Size
2.2 Fabry Disease Treatment Growth Trends by Regions
2.2.1 Fabry Disease Treatment Market Size by Regions (2019-2025)
2.2.2 Fabry Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Fabry Disease Treatment Market Size by by Players
3.1.1 Global Fabry Disease Treatment Revenue by by Players (2014-2019)
3.1.2 Global Fabry Disease Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Fabry Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Fabry Disease Treatment Key Players Head office and Area Served
3.3 Key Players Fabry Disease Treatment Product/Solution/Service
3.4 Date of Enter into Fabry Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Fabry Disease Treatment Market Size by Type (2014-2019)
4.2 Global Fabry Disease Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Fabry Disease Treatment Market Size (2014-2019)
5.2 Fabry Disease Treatment Key Players in North America
5.3 North America Fabry Disease Treatment Market Size by Type
5.4 North America Fabry Disease Treatment Market Size by Application
6 Europe
6.1 Europe Fabry Disease Treatment Market Size (2014-2019)
6.2 Fabry Disease Treatment Key Players in Europe
6.3 Europe Fabry Disease Treatment Market Size by Type
6.4 Europe Fabry Disease Treatment Market Size by Application
7 China
7.1 China Fabry Disease Treatment Market Size (2014-2019)
7.2 Fabry Disease Treatment Key Players in China
7.3 China Fabry Disease Treatment Market Size by Type
7.4 China Fabry Disease Treatment Market Size by Application
8 Japan
8.1 Japan Fabry Disease Treatment Market Size (2014-2019)
8.2 Fabry Disease Treatment Key Players in Japan
8.3 Japan Fabry Disease Treatment Market Size by Type
8.4 Japan Fabry Disease Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Fabry Disease Treatment Market Size (2014-2019)
9.2 Fabry Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Fabry Disease Treatment Market Size by Type
9.4 Southeast Asia Fabry Disease Treatment Market Size by Application
10 India
10.1 India Fabry Disease Treatment Market Size (2014-2019)
10.2 Fabry Disease Treatment Key Players in India
10.3 India Fabry Disease Treatment Market Size by Type
10.4 India Fabry Disease Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Fabry Disease Treatment Market Size (2014-2019)
11.2 Fabry Disease Treatment Key Players in Central & South America
11.3 Central & South America Fabry Disease Treatment Market Size by Type
11.4 Central & South America Fabry Disease Treatment Market Size by Application
12 International Players Profiles
12.1 Sanofi S.A.
12.1.1 Sanofi S.A. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Fabry Disease Treatment Introduction
12.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2014-2019))
12.1.5 Sanofi S.A. Recent Development
12.2 Takeda
12.2.1 Takeda Company Details
12.2.2 Company Description and Business Overview
12.2.3 Fabry Disease Treatment Introduction
12.2.4 Takeda Revenue in Fabry Disease Treatment Business (2014-2019)
12.2.5 Takeda Recent Development
12.3 Amicus Therapeutics Inc.
12.3.1 Amicus Therapeutics Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Fabry Disease Treatment Introduction
12.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2014-2019)
12.3.5 Amicus Therapeutics Inc. Recent Development
12.4 ISU Abxis Co Ltd.
12.4.1 ISU Abxis Co Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Fabry Disease Treatment Introduction
12.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2014-2019)
12.4.5 ISU Abxis Co Ltd. Recent Development
12.5 JCR Pharmaceuticals Co Ltd.
12.5.1 JCR Pharmaceuticals Co Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Fabry Disease Treatment Introduction
12.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2014-2019)
12.5.5 JCR Pharmaceuticals Co Ltd. Recent Development
12.6 Protalix Biotherapeutics Inc.
12.6.1 Protalix Biotherapeutics Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Fabry Disease Treatment Introduction
12.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2014-2019)
12.6.5 Protalix Biotherapeutics Inc. Recent Development
12.7 Idorsia Pharmaceuticals Ltd.
12.7.1 Idorsia Pharmaceuticals Ltd. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Fabry Disease Treatment Introduction
12.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2014-2019)
12.7.5 Idorsia Pharmaceuticals Ltd. Recent Development
12.8 Avrobio Inc.
12.8.1 Avrobio Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Fabry Disease Treatment Introduction
12.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2014-2019)
12.8.5 Avrobio Inc. Recent Development
12.9 Greenovation Biotech GmbH
12.9.1 Greenovation Biotech GmbH Company Details
12.9.2 Company Description and Business Overview
12.9.3 Fabry Disease Treatment Introduction
12.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2014-2019)
12.9.5 Greenovation Biotech GmbH Recent Development
12.10 Moderna Therapeutics Inc.
12.10.1 Moderna Therapeutics Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Fabry Disease Treatment Introduction
12.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2014-2019)
12.10.5 Moderna Therapeutics Inc. Recent Development
12.11 Green Cross Pharma Pte Ltd.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Sanofi S.A.、Takeda、Amicus Therapeutics Inc.、ISU Abxis Co Ltd.、JCR Pharmaceuticals Co Ltd.、Protalix Biotherapeutics Inc.、Idorsia Pharmaceuticals Ltd.、Avrobio Inc.、Greenovation Biotech GmbH、Moderna Therapeutics Inc.、Green Cross Pharma Pte Ltd.